Want to learn more about what we do here at Helix? Here's a quick introduction from our leadership team: https://hubs.ly/Q018wD7R0
Helix
Hospitals and Health Care
San Mateo, California 20,024 followers
Helix is the leading population genomics and viral surveillance company.
About us
We enable health systems, public health, and life science companies to integrate genomics throughout their enterprise. Our solutions transform healthcare, medical research, diagnosis, treatment, and prevention. By making genomics accessible and actionable, we empower our clients to deliver personalized and effective healthcare at scale. Learn more at www.helix.com.
- Website
-
http://www.helix.com
External link for Helix
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- San Mateo, California
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Next Generation Sequencing (NGS), Bioinformatics, Big Data, DNA, Population Health, Population Genomics, Precision Health, Precision Medcine, Exome Sequencing, Medical Research, and Health System Strategy
Locations
-
Primary
101 S Ellsworth Ave
San Mateo, California 94401, US
Employees at Helix
Updates
-
#InTheNews: Thanks to GenomeWeb for covering the news of the launch of our clinico-genomic datasets, aiding life science companies in developing new drugs and targeting multiple therapeutic areas such as heart conditions, immunology, and more. Read up on the details: https://bit.ly/4bTePxc
-
#InTheNews: Learn more about Lynch syndrome, its impact on cancer risk, and the benefits of genetic testing to cover high-risk genes associated with hereditary diseases in a piece about the Genetic Insights Project, partnering with Nebraska Medicine. https://bit.ly/3VfhUk1
What is Lynch syndrome, and how does it affect your cancer risk?
nebraskamed.com
-
#InTheNews: Our CEO and co-founder James Lu, M.D. Ph.D speaks to Inside Precision Medicine about bringing genetic testing to population scale, enrolling up to 100,000 local participants at a time in partnerships with Sanford Health, Cone Health, Medical University of South Carolina, and others. Read more about the importance of genomics in population health: https://bit.ly/3Va2AoM
Consumer Genomics: How to Engage Patients with DNA Testing
https://www.insideprecisionmedicine.com
-
#InTheNews: Thank you to The Cancer Letter for featuring a piece for their monthly issue penned by Helix's Medical Director, Cassie Hajek, MD FACP, FACMG, focusing on providing the proper risk typing for genetic screening and the benefits of determining low-risk patients. You can read her article here: https://bit.ly/45mHmsn
Are we focused on the wrong risk type in genetic screening? Breast cancer screening study shows new paths to population screening - The Cancer Letter
cancerletter.com
-
We are proud to announce the launch of new clinico-genomic datasets to enable life science companies to drive precision medicine drug discovery and development. Built through Helix’s extensive health system partnerships, these population-scale cohorts consist of full longitudinal clinical and genomic records that span multiple therapeutic areas including Cardiovascular, Immunology & Inflammation and Metabolic conditions. Helix CEO and co-founder James Lu, M.D. Ph.D: “As the number of precision therapies in development continues to rapidly expand, clinico-genomic data provide incredible opportunities to develop targeted therapeutics with better safety and efficacy profiles.” Hylton Kalvaria, Chief Commercial Officer of Helix: “Life science researchers can utilize Helix’s diverse clinico-genomic cohorts to better understand genetic factors associated with disease progression and clinical outcomes, as well as validating therapeutic candidates of interest.” #lifesciences #genomics #drugdiscovery #precisionmedicine You can read more about today’s announcement here: https://bwnews.pr/4b0Grip
Helix Launches Clinico-Genomic Datasets for Cardiovascular, Metabolic, Immunology and Inflammation Disorders
businesswire.com
-
At #BIO2024 this week in San Diego, CA? Meet our experts, Hylton Kalvaria and Ariana Lichtenstein to learn how life sciences can utilize linked clinico-genomic datasets to drive #drugdiscovery and development in the age of precision medicine! Learn more and Request a meeting here: https://bit.ly/4bHhs4T #BIO2024 #PrecisionMedicine #DrugDiscovery #Pharma
BIO One-on-One Partnering
login.partnering.bio.org
-
#InTheNews: Colleen O'Kelly Priddy, MD FACS and Jamie Schnell Blitstein discuss the latest results published from our partnership with Renown Health's Healthy Nevada Project, detailing the success of genetic screenings for breast cancer risk assessments. Watch here: https://bit.ly/3yB53ko
Well-Being Wednesday: The role of genetics in breast cancer screenings
foxreno.com
-
Visiting #BIO2024 next week in San Diego, CA? Meet our experts Hylton Kalvaria and Ariana Lichtenstein to learn how life sciences can utilize linked clinico-genomic data to drive #drugdiscovery and development in the age of precision medicine. Request a meeting here: https://bit.ly/3Xa2nol #BIO2024 #PrecisionMedicine #DrugDiscovery #Pharma
BIO One-on-One Partnering
login.partnering.bio.org
-
#InTheNews: Community health research can help participants today and in the future. Read more about how we partnered with Nebraska Medicine's Genetic Insights Project to not only screen hereditary conditions that have actionable insights now, but assist with therapies for patients in the future. https://bit.ly/3wPdR5U
Genetic Insights Project helps Nebraskans take charge of their health
nebraskamed.com